Investing
178 Articles
Illumina (NASDAQ: ILMN) shareholders may be in for a rude surprise. Suitor Roche could be close to walking away from a…
Biotech is a sector which is often mixed with a hodge-podge of winners and losers based on news flow from…
Google (NASDAQ: GOOG) splits its stock in a way that will help its founders keep control, and the company also…
Apartment vacancy rates reach a 10-year low, according to Reis. (Reuters) Tom Glocer, the departing head of Thomson Reuters (NYSE:…
Apple’s (NASDAQ: AAPL) iPad is the number one tablet PC in a new Consumer Reports survey. (Reuters) CEO pay jumps…
The heads of the BRIC nations say the pace of IMF-led reforms concerns them. (Reuters) Facebook cuts trading of its stock…
Microsoft (NASDAQ: MSFT) struggles with its Windows Mobile OS as app developers have been slow to adopt it. (Reuters) Smugglers…
The BP (NYSE: BP) oil trial is delayed for settlement talks. (Reuters) G20 ministers and central banks say Europe has…
The Greeks try to get a financial aid package while some regional leaders say the eurozone does not need the…
Genetic biotech company Illumini (NASDAQ: ILMN) rejected an offer, now hostile, made by drug giant Roche. The Illimina board said…
Illumina, Inc. (NASDAQ: ILMN) is the subject of a Roche takeover at $44.50 per share now, but many investors are…
Illumina Inc. (NASDAQ: ILMN) had a solid day on Wednesday due to a hostile bid from Roche (RHHBY). The hope…
Ben Bernanke says the Fed is prepared to buy more bonds. (Reuters) NEC to cut 10,000 workers. (Reuters) Nintendo posts…
Markets opened mixed this morning, with the DJIA and S&P 500 opening lower and the Nasdaq Composite opening higher. The…
There are several stocks trading more heavily than usual this morning, and also experiencing large gains or drops in share…
Our top personal finance-related articles today. Your wallet will thank you later.